Looking back at the charts, it seems that a gradual uptick for this company started in january 09, after bottoming out. I assume the upward trend that started 4 years ago, was due to ponatinib coming to fruition, right up to approval last month. All other future variables aside, I was wandering if a similar gradual upward pattern in price will start solely based on 113. And if so when?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.